STOCK TITAN

Aegis Capital Corp. Acted as Sole Bookrunner on a $8.5 Million Follow-On Offering for Medigus Ltd. (Nasdaq: MDGS)

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Medigus Ltd. (Nasdaq: MDGS) successfully completed an $8.5 million follow-on offering, facilitated by Aegis Capital Corp. as the sole bookrunner. The funds raised will support Medigus' focus on medical devices and internet technologies, including its innovative surgical technology for treating GERD and miniaturized imaging equipment through its subsidiary Scoutcam. The offering aims to enhance Medigus' capabilities in both medical and digital sectors, reflecting the company's ambition for growth and innovation.

Positive
  • Raised $8.5 million through a follow-on offering to support business expansion.
  • Focus on innovative medical technologies and internet solutions.
  • Partnership with Aegis Capital Corp. enhances financial strategy.
Negative
  • None.

NEW YORK, NY / ACCESSWIRE / March 1, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $8.5 Million Follow-On Offering for Medigus Ltd. (Nasdaq: MDGS)

About Medigus Ltd.

Medigus and its subsidiaries are focused on medical-related devices and products and on internet and other online-related technologies. Their medical-related activities include miniaturized imaging equipment through Scoutcam Inc. (formerly known as Intellisense Solutions Inc.), or Scoutcam, their 46.03% held subsidiary, innovative surgical devices with direct visualization capabilities for the treatment of Gastroesophageal Reflux Disease, or GERD, by the Company using Medigus Ultrasonic Surgical Endostapler, or MUSE, and biological gels to protect patients against biological threats and prevent intrusion of allergens and viruses through the upper airways and eye cavities through their stake and licensing arrangement with Polyrizon Ltd., or Polyrizon. Their internet-related activities include ad-tech operations through their stake in Gix Internet Ltd., f/k/a Algomizer Ltd., or Gix, and its subsidiary, Linkury Ltd., or Linkury. Medigus also entered into agreements to acquire stakes in Eventer Technologies Ltd., an online event management and ticketing platform and SmartRepairPro, an e-commerce technology company.

About Aegis Capital Corp.

Aegis Capital Corporation ("Aegis") has been in the wealth management and investment banking business since 1984. Aegis is dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. Aegis also provides research and sales and trading services to institutional investors. Aegis offers its investment representatives a conflict free service platform and is able to provide a full-range of products and services.

For more information about this offering or Investment Banking Services please email InvestmentBanking@aegiscap.com or call (212) 813-1010

www.aegiscapcorp.com

This communication has been prepared by Aegis Capital Corporation for distribution to Aegis Capital Corporation's clientele. This communication is not intended for public dissemination and the recipient is prohibited from sharing this information. This communication has been prepared for institutional - accounts, as defined within FINRA Rule 4512(c), who (1) are capable of evaluating investment risks independently, both in general and with regard to all transactions and investment strategies involving a security or securities; and (2) will exercise independent judgment in evaluating the recommendations of any broker - dealer or its associated persons. This communication is not a product of Aegis Capital Corporation Research Department. Aegis Capital Corporation., Member FINRA, SIPC

SOURCE: Aegis Capital Corp.



View source version on accesswire.com:
https://www.accesswire.com/632785/Aegis-Capital-Corp-Acted-as-Sole-Bookrunner-on-a-85-Million-Follow-On-Offering-for-Medigus-Ltd-Nasdaq-MDGS

FAQ

What was the amount raised in Medigus' latest offering?

Medigus raised $8.5 million in its recent follow-on offering.

Who was the sole bookrunner for Medigus' follow-on offering?

Aegis Capital Corp. acted as the sole bookrunner for the offering.

What is Medigus focusing on with the funds raised from the offering?

Medigus intends to advance its medical-related devices and internet technologies.

What is the stock symbol for Medigus?

Medigus is traded under the stock symbol MDGS.

Medigus Ltd. American Depositary Share

NASDAQ:MDGS

MDGS Rankings

MDGS Latest News

MDGS Stock Data

4.47M
28.42M
0.29%
0.22%
Medical Devices
Healthcare
Link
United States of America
Tel Aviv